Literature DB >> 16708060

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed.

D T Vogl, E A Stadtmauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16708060     DOI： 10.1038/sj.bmt.1705366

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Authors:  Syed O A Ahmed; Ardeshir Ghavamzadeh; Syed Z Zaidi; Helen Baldomero; Marcelo C Pasquini; Fazal Hussain; Kamran Alimoghaddam; Fahad Almohareb; Mouhab Ayas; Amir Hamidieh; Hossam K Mahmoud; Alaa Elhaddad; Tarek Ben Othman; Abdelrahman Abdelkefi; Mahmoud Sarhan; Fawzi Abdel-Rahman; Salman Adil; Salam Alkindi; Ali Bazarbachi; Said Benchekroun; Dietger Niederwieser; Mary Horowitz; Alois Gratwohl; Hassan El Solh; Mahmoud Aljurf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-01       Impact factor: 5.742

2.  High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.

Authors:  Donald A Berry; Naoto T Ueno; Marcella M Johnson; Xiudong Lei; Jean Caputo; Dori A Smith; Linda J Yancey; Michael Crump; Edward A Stadtmauer; Pierre Biron; John P Crown; Peter Schmid; Jean-Pierre Lotz; Giovanni Rosti; Marco Bregni; Taner Demirer
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

3.  Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice.

Authors:  Hongwei Wang; Madhukumar Venkatesh; Hao Li; Regina Goetz; Subhajit Mukherjee; Arunima Biswas; Liang Zhu; Andreas Kaubisch; Lei Wang; James Pullman; Kathleen Whitney; Makoto Kuro-o; Andres I Roig; Jerry W Shay; Moosa Mohammadi; Sridhar Mani
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

4.  Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J Kuball; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2016-11-07       Impact factor: 5.483

Review 5.  Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer.

Authors:  Fleur Huang; Yael B Kushner; Adrian Langleben; William D Foulkes
Journal:  Nat Rev Clin Oncol       Date:  2009-08       Impact factor: 66.675

Review 6.  Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review.

Authors:  Sigrid Droste; Annegret Herrmann-Frank; Fueloep Scheibler; Tanja Krones
Journal:  BMC Med Ethics       Date:  2011-04-15       Impact factor: 2.652

7.  Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.

Authors:  Israel Henig; Tsila Zuckerman
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

8.  Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice.

Authors:  Hyunju Liu; Jung In Lee; Tae-Gyu Ahn
Journal:  Obstet Gynecol Sci       Date:  2019-06-19

Review 9.  Noninfectious Acute Lung Injury Syndromes Early After Hematopoietic Stem Cell Transplantation.

Authors:  Vivek N Ahya
Journal:  Clin Chest Med       Date:  2017-09-19       Impact factor: 2.878

10.  Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.

Authors:  D Niederwieser; H Baldomero; J Szer; M Gratwohl; M Aljurf; Y Atsuta; L F Bouzas; D Confer; H Greinix; M Horowitz; M Iida; J Lipton; M Mohty; N Novitzky; J Nunez; J Passweg; M C Pasquini; Y Kodera; J Apperley; A Seber; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.